Tonix Pharmaceuticals stock halted ahead of FDA approval news
Tuesday, Boeing (NYSE:BA) stock (currently trading at $175.16 with a market capitalization of $131 billion) maintained its Market Perform rating and a price target of $169.00, as reiterated by Bernstein SocGen Group. According to InvestingPro data, five analysts have recently revised their earnings expectations downward, with analyst targets ranging from $85 to $250 per share. The firm's analysis acknowledged Boeing's preannounced fourth-quarter losses, which were in line with their expectations. The announcement primarily addressed significant defense program charges totaling $1.7 billion, notably affecting the KC-46 tanker and T-7A trainer aircraft. These charges were a point of concern for analysts, as they were not solely attributable to the IAM strike.
Bernstein analysts pointed to the need for Boeing to limit further downside risks in defense, despite the ongoing charges. The company is anticipated to progress with the 737MAX production ramp-up and to resume widebody aircraft deliveries. InvestingPro analysis reveals concerning fundamentals, with a weak gross profit margin of 3.62% and an overall Financial Health Score rated as WEAK, suggesting significant operational challenges ahead. However, Bernstein highlighted that substantial efforts are still required. The analysts emphasized the importance of Boeing's delivery and production projections for 2025, noting that January's widebody delivery figures were particularly weak.
The firm is looking for Boeing to present clear recovery plans with measurable goals and a strengthened management team to ensure adherence to these plans. The analysts also noted that under the new Trump administration, there has been no significant change in government oversight of the company. Additionally, there is ongoing uncertainty surrounding the potential impact of tariffs, especially concerning China. Despite these concerns, Boeing's deliveries to China have continued.
In summary, Bernstein SocGen Group's stance on Boeing remains cautious, with a focus on the company's ability to navigate challenges in defense program charges, production ramp-up, and geopolitical uncertainties. For deeper insights into Boeing's financial health and future prospects, InvestingPro offers comprehensive analysis through its Pro Research Report, featuring detailed metrics, expert analysis, and fair value assessments among 1,400+ top US stocks. The firm's price target of $169.00 reflects this cautious optimism, pending further developments in Boeing's recovery plans and external factors affecting the aerospace industry.
In other recent news, United Airlines experienced a significant incident with a Boeing 787-8 flight which had to return to Lagos due to loss of cabin pressure, resulting in 33 passengers injured. In financial news, Boeing encountered substantial losses in the fourth quarter due to strikes and additional Defense charges. Vertical Research Partners maintained a Hold rating on Boeing with a price target of $160, while Citi analysts adjusted their outlook, reducing the price target from $209 to $207, but maintained a Buy rating. Barclays (LON:BARC) upgraded Boeing stock from Equalweight to Overweight, anticipating positive momentum in production and deliveries through 2025. Boeing's potential sale of its Jeppesen navigation unit has attracted attention from major aviation suppliers and private equity firms as part of its strategy to streamline operations. These are the recent developments concerning Boeing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.